On October 10th, Gelonhui, Hongbo Pharmaceutical, surged by 20cm, while Xiangxue Pharmaceutical, Chempartner Pharmatech, Haichuang Pharmaceutical, Shanxi C&Y Pharmaceutical Group increased by over 10%, with Betta Pharmaceuticals, Fujian Cosunter Pharmaceutical, Haoyuan Pharmaceuticals, Sichuan Kelun Pharmaceutical ranking high in terms of growth. On the news front, on October 9th, the General Office of the Guangdong Provincial Government issued a notice on further promoting the high-quality development of the biomedical industry in Guangdong, proposing full industry chain support for the biomedical and health industries. Striving for by 2027, the scale of the biomedical and health industry cluster in Guangdong Province to exceed one trillion yuan, the scale of the pharmaceutical industry above designated size to exceed 500 billion yuan, forming a group of specialized, special and new, 'unicorn' and single champion enterprises in segmented fields.